Inflammation in the body is beneficial, but too much of a good thing can be bad. Especially when excess, unregulated inflammation in the intestines leads to chronic diarrhea caused by a condition ...
Company strategy: In discussions with multiple potential animal health company partners to collaborate to bring Canalevia ®, conditionally approved for CID, to regulatory approval and ...
SAN FRANCISCO, CA / ACCESS Newswire / August 21, 2025 / Jaguar Health, Inc. (NASDAQ:JAGX) (“Jaguar”), under its Jaguar Animal Health tradename for the veterinary market, today announced it is ...
“Specifically, our objective is to partner with an animal health company to achieve three parallel goals for Canalevia: Expand the U.S. indication from CID in dogs to treatment of general diarrhea in ...
SAN FRANCISCO, CA / ACCESS Newswire / August 21, 2025 / Jaguar Health, Inc. (NASDAQ:JAGX) (“Jaguar”), under its Jaguar Animal Health tradename for the veterinary market, today announced it is ...